Effect of imidapril or amlodipine on the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus: a randomized controlled study

Effect of imidapril or amlodipine on the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus: a randomized controlled study - Effect of imidapril on the progression of diabetic nephropathy with type 2 DM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001714

Enrollment

100

Registered

2009-02-17

Start date

2001-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus with hypertension

Interventions

imidapril amlodipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: outpatient BP>130/85(no medication) Cre<2.5 mg/dl

Exclusion criteria

Exclusion criteria: renal stenosis and high renin activity modelate liver injury blood control poor pregnancy

Design outcomes

Primary

Measure	Time frame
urinary albumin excretion of imidapril	—

Countries

Japan

Contacts

Public ContactToshinari takamura

Kanazawa University Graduate School of Medical Science Department of Disease Control and Homeostasis

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026